Catalyst Event
Joinn Laboratories (China) Co Ltd (6127) · Earnings Release
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
4/29/2026, 12:00:00 AM
Announced Q1 2026 results on 2026-04-29: Net profit surged 479.7% YoY to RMB 238 million, primarily due to gains from the fair value change of biological assets, while revenue increased 10% YoY to RMB 316 million. Medium importance is estimated as the profit surge is primarily driven by non-cash fair value changes, likely resulting in a 5-10% price impact. expected
Korean Translation
2026년 4월 29일 2026년 1분기 실적 발표: 매출은 전년 동기 대비 10% 증가한 3.16억 위안, 순이익은 주로 생물자산 공정가치 변동 이익으로 인해 전년 동기 대비 479.7% 급증한 2.38억 위안을 기록함. 비현금성 이익인 생물자산 공정가치 변동이 주된 요인으로, 5~10%의 주가 영향이 예상되어 'Medium'으로 평가함. 예상됨
Related Recent Events
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date for the final dividend of RMB 1.43 per share for the fiscal year 2025 on 2026-06-16, scheduled.
6/16/2026, 12:00:00 AM
Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other
Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled
5/21/2026, 12:00:00 AM
Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other
An earnings briefing for the 2025 fiscal year and Q1 2026 results is scheduled for May 14, 2026. This routine communication event is estimated to have a price impact of at least 1% scheduled.
5/14/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
Caris Life Sciences to report first quarter 2026 financial results on May 7, 2026, scheduled.
5/7/2026, 12:00:00 AM
Guardant Health Inc (GH) · Earnings Release
Guardant Health is scheduled to release its Q1 2026 financial results after market close on May 7, 2026. Analysts forecast EPS of ($0.47) and revenue of $279.17 million. High importance estimated due to potential for significant volatility following earnings results, scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, with analysts forecasting revenue of approximately $617.5 million and an EPS of -$0.55; high importance is expected due to typical earnings volatility, scheduled.
5/7/2026, 12:00:00 AM